Neurologic outcomes were evaluated in a randomized trial of TAVR or surgical aortic valve replacement (SAVR) for severe AS (750 pts).
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
TAVR (TAVI)
April 5, 2016
In this manuscript the authors report on their findings in a systematic review and meta-analysis of 18 studies looking into the effect on outcomes of balloon predilatation in patients undergoing transcatheter aortic valve implantation (TAVI).
April 3, 2016
Neil Moat, one of the busiest British surgeons involved directly and consistently in TAVR, discusses PARTNER 2 and SURTAVI, paying particular attention to the health economics of low-risk TAVR and the implication of reduced profile devices.
April 3, 2016
The PARTNER 2A trial randomized 2032 patients at intermediate operative risk (mean STS score of 6) to undergo either transcatheter or surgical aortic valve replacement. The primary endpoint of all-cause death or disabling stroke at 2 years was comparable for the two treatments: TAVR 19.3% versus SAVR 21.1%.
March 31, 2016
A panel of leading cardiac surgeons met at the 2016 SCTS Annual Meeting in Birmingham, United Kingdom, to discuss the current state of cardiac surgery, and what is on the horizon for the subspecialty.
March 28, 2016
A refreshing , adequately supported by pragmatic imaging, 22 minute presentation from an Arizona meeting that many surgeons would find quite informative and educating. Dr.
March 22, 2016
In this study the STS/ACC Transcatheter Valve Therapy registry was used to compare TAVI in nonogenarians versus TAVI in patients <90 years old. In total 3,773 (15.7%) of the patients were >90 years old. Mortality at 30 days and 1-year was significantly higher for nonogenarians (8.8% vs. 5.9%, p<0.001 and 24.8% vs.
March 20, 2016
This instructive paper includes three separate meta-analyses focusing on patient-prosthesis mismatch (PPM) after TAVR. These meta-analyses revealed the following:
March 7, 2016
This literature review evaluated 21 studies that included nearly 4000 patients having undergone transcatheter aortic valve implantation (TAVI), specifically focusing on prosthesis-patient mismatch (PPM). Overall prevalence of PPM was 35%, with 8% of patients having severe PPM. PPM occurred less often after TAVI than after surgical AVR. PPM was not
February 10, 2016
The video shows the explantation of a Corevalve through a minimally invasive inferior ministernotomy approach.